Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Price to Book Value : 7.052 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.264 |
| November 11, 2026 | 7.230 |
| November 10, 2026 | 7.205 |
| November 09, 2026 | 7.283 |
| November 06, 2026 | 6.416 |
| November 05, 2026 | 6.154 |
| November 04, 2026 | 6.265 |
| November 03, 2026 | 6.912 |
| November 02, 2026 | 6.620 |
| October 30, 2026 | 6.999 |
| October 29, 2026 | 7.786 |
| October 28, 2026 | 7.846 |
| October 27, 2026 | 7.303 |
| October 26, 2026 | 6.951 |
| October 23, 2026 | 7.020 |
| October 22, 2026 | 6.798 |
| October 21, 2026 | 7.194 |
| October 20, 2026 | 6.441 |
| October 19, 2026 | 6.016 |
| October 16, 2026 | 5.782 |
| October 15, 2026 | 6.272 |
| October 14, 2026 | 5.803 |
| October 13, 2026 | 5.380 |
| October 12, 2026 | 5.544 |
| October 09, 2026 | 5.780 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.926 |
| October 07, 2026 | 6.352 |
| October 06, 2026 | 7.379 |
| October 05, 2026 | 8.722 |
| October 02, 2026 | 7.859 |
| October 01, 2026 | 7.425 |
| September 30, 2026 | 7.793 |
| September 29, 2026 | 7.241 |
| September 28, 2026 | 7.232 |
| September 25, 2026 | 7.275 |
| September 24, 2026 | 7.363 |
| September 23, 2026 | 7.128 |
| September 22, 2026 | 7.368 |
| September 21, 2026 | 7.774 |
| September 18, 2026 | 7.729 |
| September 17, 2026 | 7.099 |
| September 16, 2026 | 6.516 |
| September 15, 2026 | 6.376 |
| September 14, 2026 | 6.208 |
| September 11, 2026 | 6.186 |
| September 10, 2026 | 6.159 |
| September 09, 2026 | 6.423 |
| September 08, 2026 | 6.642 |
| September 04, 2026 | 6.831 |
| September 03, 2026 | 6.78 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Personalis, Inc. | 8.003 |
| 10X Genomics, Inc. | 9.128 |
| Champions Oncology, Inc. | 16.73 |
| Medpace Holdings, Inc. | 31.17 |
| Avantor, Inc. | 1.803 |
Price to Book Value Related Metrics
| PS Ratio | 19.64 |
| PEG Ratio | -0.1366 |
| Price | 30.83 |
| Earnings Yield | -2.61% |
| Market Cap | 2.142B |
| PEGY Ratio | -0.1366 |